“医生，我脚底的伤口好了，假期我终于实现了期待好久的周边游小目标，谢谢你们了。” 国庆假期刚过，来自河南的患者小雅（化名）向绵阳市中心医院血管外科、输血科、伤口治疗中心的MDT团队发来感谢信息，分享她因病情好转而激动的心情。 小雅今年25岁，漂亮活泼 ...

为了提高抗肿瘤的疗效，该患者采用了交替输注CIK细胞和NK细胞的治疗方案，并取得了良好的结果。患者 已处于NED状态40个月 ，并将继续保持该状态。NED就是无疾病状态（No Evidence of ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

接种癌症疫苗的本质在于激活人体免疫系统，使之精准识别并有效攻击癌细胞。该疗法的首要目标是控制肿瘤的生长，预防其复发或转移，并强化免疫系统识别和清除癌细胞的能力。癌症疫苗的作用机理在于诱发针对特定肿瘤相关抗原（TAA，即由癌细胞表达的独特蛋白质）的免疫 ...

The CardiAMP HF Trial is assessing the safety and effectiveness of the CardiAMP ® Cell Therapy System for HFrEF, with the potential to reduce all cause death, future hospitalizations, enhance ...

IN A breakthrough study, researchers have reported encouraging outcomes using autologous chimeric antigen receptor (CAR) T ...

Dr L J Salmon, North Sydney Orthopaedic and Sports Medicine Centre, 286 Pacific Hwy, Crows Nest, Sydney NSW 2065, Australia; lsalmon{at}nsosmc.com.au If you wish to ...

近日，2024年亚洲肺癌大会（ACLC）举行。莆田市第一医院胸心外科许志扬教授、许建新副教授团队受邀参会，其团队研究成果《Risk factors of pneumothorax in computed tomography guided lung nodule marking using autologous ...

Company expects to commence Phase 3 trial of Descartes-08 in patients with myasthenia gravis in 1H2025 following recent meeting with U.S. Food ...

Murali Ramachandra, CEO, Aurigene Oncology Limited. Ribrecabtagene autoleucel is an autologous anti-BCMA CAR-T therapy that utilizes a humanized single-domain antibody as the antigen binding ...